Susquehanna International Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $571K | Sell |
237,090
-72,453
| -23% | -$175K | ﹤0.01% | 4139 |
|
|
2025
Q1 | $684K | Buy |
309,543
+181,225
| +141% | +$401K | ﹤0.01% | 3912 |
|
|
2024
Q4 | $699K | Buy |
128,318
+115,007
| +864% | +$627K | ﹤0.01% | 3534 |
|
|
2024
Q3 | $111K | Sell |
13,311
-96,368
| -88% | -$801K | ﹤0.01% | 5091 |
|
|
2024
Q2 | $785K | Sell |
109,679
-291,458
| -73% | -$2.09M | ﹤0.01% | 2874 |
|
|
2024
Q1 | $3.48M | Sell |
401,137
-187,005
| -32% | -$1.62M | ﹤0.01% | 1280 |
|
|
2023
Q4 | $3.85M | Sell |
588,142
-366,597
| -38% | -$2.4M | ﹤0.01% | 1351 |
|
|
2023
Q3 | $9.55M | Sell |
954,739
-1,484,339
| -61% | -$14.8M | ﹤0.01% | 729 |
|
|
2023
Q2 | $30.3M | Buy |
2,439,078
+1,765,967
| +262% | +$22M | 0.01% | 289 |
|
|
2023
Q1 | $9.43M | Buy |
673,111
+517,180
| +332% | +$7.25M | ﹤0.01% | 768 |
|
|
2022
Q4 | $2.23M | Buy |
155,931
+32,915
| +27% | +$471K | ﹤0.01% | 1509 |
|
|
2022
Q3 | $3.14M | Sell |
123,016
-92,135
| -43% | -$2.35M | ﹤0.01% | 1220 |
|
|
2022
Q2 | $6.11M | Buy |
215,151
+171,398
| +392% | +$4.87M | ﹤0.01% | 800 |
|
|
2022
Q1 | $1.54M | Buy |
43,753
+32,744
| +297% | +$1.15M | ﹤0.01% | 2308 |
|
|
2021
Q4 | $461K | Buy |
11,009
+4,200
| +62% | +$176K | ﹤0.01% | 3923 |
|
|
2021
Q3 | $334K | Sell |
6,809
-6,921
| -50% | -$339K | ﹤0.01% | 4176 |
|
|
2021
Q2 | $573K | Sell |
13,730
-29,769
| -68% | -$1.24M | ﹤0.01% | 3736 |
|
|
2021
Q1 | $1.55M | Buy |
+43,499
| New | +$1.55M | ﹤0.01% | 2407 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5108 |
|